![logo](/logos/MGTX.webp)
MeiraGTx Holdings plc
NASDAQ:MGTX
3.88 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | MeiraGTx Holdings plc |
Symbool | MGTX |
Munteenheid | USD |
Prijs | 3.88 |
Beurswaarde | 300,307,732 |
Dividendpercentage | 0% |
52-weken bereik | 3.49 - 7.6 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Alexandria Forbes Ph.D. |
Website | https://www.meiragtx.com |
An error occurred while fetching data.
Over MeiraGTx Holdings plc
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis;
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)